MedPath

Delayed Cord Clamping for Congenital Diaphragmatic Hernia

Not Applicable
Completed
Conditions
Congenital Diaphragmatic Hernia
Interventions
Procedure: DING
Registration Number
NCT03314233
Lead Sponsor
Children's Hospital of Philadelphia
Brief Summary

Congenital diaphragmatic hernia (CDH) is a congenital anomaly associated with a high risk of mortality and need for life-saving interventions such as extracorporeal membrane oxygenation (ECMO), nitric oxide, and vasopressor support. Although infants with CDH experience significant morbidity and mortality starting immediately after birth, high quality evidence informing delivery room resuscitation in this population is lacking.

Infants with CDH are at risk for pulmonary hypoplasia and pulmonary hypertension and often experience hypoxemia and acidosis during neonatal transition. The standard approach to DR resuscitation is immediate umbilical cord clamping (UCC) followed by intubation and mechanical ventilation. Animal models suggest that achieving lung aeration prior to UCC results in improved pulmonary blood flow and cardiac function compared with immediate UCC before lung aeration is established. Trials of preterm infants demonstrated that initiating respiratory support prior to UCC is safe and feasible. Because infants with CDH are at high risk for pulmonary hypertension and systemic hypotension, they may benefit from the hemodynamic effects of lung aeration before UCC, namely increased pulmonary blood flow, decreased pulmonary vascular resistance, and improved cardiac output. To date, this approach has not been studied in infants with CDH.

Detailed Description

Congenital diaphragmatic hernia (CDH) is a congenital anomaly associated with a high risk of mortality (29%) and need for life-saving interventions such as ECMO (33%), nitric oxide (62%), and vasopressor support (73%).1 Although infants with CDH experience significant morbidity and mortality starting immediately after birth, high quality evidence informing delivery room resuscitation in this population is lacking.

Infants with CDH are at risk for pulmonary hypoplasia and pulmonary hypertension and often experience hypoxemia and acidosis during neonatal transition. The standard approach to delivery room (DR) resuscitation is immediate UCC followed by intubation and mechanical ventilation. The goals of this strategy are to immediately recruit and aerate the lung for gas exchange and oxygenation, while simultaneously avoiding gaseous distention of the thoracic gastrointestinal contents.

Animal models suggest that achieving lung aeration prior to UCC results in improved pulmonary blood flow and cardiac function compared with immediate UCC before lung aeration is established. Trials of preterm infants demonstrated that initiating respiratory support prior to UCC is safe and feasible. Because infants with CDH are at high risk for pulmonary hypertension and systemic hypotension, they may benefit from the hemodynamic effects of lung aeration before UCC, namely increased pulmonary blood flow, decreased pulmonary vascular resistance, and improved cardiac output.

The investigators hypothesize that a sequence of intubation, gentle ventilation, and then umbilical cord clamping will result in improved cardiovascular transition after birth in infants with CDH. To date, this approach has not been studied in infants with CDH. The DING trial will assess the feasibility and safety of this intervention in infants with CDH.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  1. Antenatal diagnosis of CDH, with care in the Center for Fetal Treatment
  2. Gestational age ≥ 36 weeks at birth
Exclusion Criteria
  1. Multiple gestation
  2. Major anomalies or aneuploidy
  3. Enrolled in fetal endoluminal tracheal occlusion (FETO) trial
  4. Palliative care planned or considered
  5. Maternal diagnosis placenta previa, accreta, or abruption
  6. Maternal diagnosis pre-eclampsia requiring Magnesium sulfate therapy at time of delivery
  7. Obstetrics (OB) or Neonatal provider concerns for the clinical care of the mother or infant, or study team not available

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DING interventionDINGDelayed Cord Clamping
Primary Outcome Measures
NameTimeMethod
Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping3 minutes of life

Infants who are intubated and have ventilation initiated prior to umbilical cord clamping

Secondary Outcome Measures
NameTimeMethod
Presence of Severe Pulmonary HypertensionApproximately 24 hours of life

Presence of severe pulmonary hypertension on first echocardiogram

Proportion of Infants Who Require Extracorporeal Membrane Oxygenation (ECMO) Treatment7 days of life

Proportion of infants who require ECMO treatment in first 7 days of life

Mean Partial Pressure of O2 in Arterial Blood (PaO2)Approximately 1 hour of life

Arterial PaO2 on first blood gas

Mean Arterial Potential of Hydrogen (pH) in Arterial BloodApproximately 1 hour of life

Arterial pH on first blood gas

Oxygenation Index (OI)First obtained blood gas

Oxygenation index \[OI\] with first obtained blood gas

Proportion of Infants Who Require VasopressorsFirst 48 hours of life

Proportion of infants who require vasopressors in first 48 hours of life

Mortality in First 7 Days of LifeFirst 7 days of life

Proportion of infants with mortality in the first 7 days of life

Trial Locations

Locations (1)

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath